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Purpose: Although management of extensive type I and II thoracoabdominal aortic 
aneurysms (TAA) remains a formidable challenge, results of repair of TAA originating in 
the distal thoracic aorta (type IV) appear to have improved significantly. To quantitate this 
perceived improvement, the following retrospective study was undertaken toexamine the 
results of type IV TAA repair at the Brigham & Women's Hospital over the past 18-year 
period. 
Methods: From July 1977 to September 1994, nonruptured atherosclerotic ype IV TAAs 
were repaired in 58 patients. The mean age was 70 years, and associated risk factors 
included smoking (91%), hypertension (86%), coronary artery disease (52%), and previous 
aortic surgery (38%). Mean follow-up was 2.4 years (median 2 years). 
Results: Overall 30-day mortality was 5.3% (two deaths). Morbidity included stroke 
(3.5%), paraplegia (1.8%), permanent paraparesis (1.8%), myocardial infarction (7%), 
pneumonia (8.8%), gastrointestinal bleeding (11%), intestinal ischemia (5.3%), wound 
infection (7.0%), peripheral ischemia (5.3%), in-hospital dialysis (8.8%), and permanent 
dialysis (1.9%). Overall 5-year survival was 50%. With univariate analysis, survival was 
positively correlated with more recent year of operation (p = 0.002), smaller volume of 
intraoperative blood transfusion (p = 0.02), decreased supraceliac ischemia time 
(p = 0.04), and the use of the retroperitoneal approach (p = 0.09). Multiple regression 
analysis revealed that the year of operation was the only independent predictor of survival 
(p = 0.003). Subgroup analysis of patients who underwent operation between 1977 and 
1987 (n = 13) and 1988 and 1994 (n = 45) revealed statistically significant improve- 
ments in length of hospital stay (46 + 12 vs 21 + 4 days, p = 0.02), postoperative 
dysrhythmia (50% vs 16%, p = 0.03), postoperative maximum serum glutamic oxaloacetic- 
transaminase (516 + 234 vs 319 + 139 mg%, p = 0.04), incidence of hemorrhage r quir- 
ing reexploration (33% vs 0%, p = 0.002), 30-day mortality (23% vs 0%, p = 0.009), and 
in-hospital mortality (39% vs 2.2%, p = 0.002). 
Conclusions: The modern mortality, morbidity, and survival of surgical repair of type IV 
TAA in our institution approaches that of infrarenal abdominal aortic aneurysm. (J Vase 
Surg 1996;24:74-81.) 
Since the initial successes with repair of thoraco- 
abdominal aortic aneurysm (TAA) reported by Ether- 
edge et al) and DeBakey et al.2 in the 1950s, TAA 
repair has remained among the most challenging and 
complex of cardiovascular operations. Despite exten- 
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sivc clinical and experimental efforts, the reported 
mortality varies from 0% to 35% in large series. 3-~5 
Furthermore, the complications in survivors can bc 
devastating including neurologic dysfunction i 0% to 
24% and renal failure requiring dialysis in 0% to 26%. 
A previous report from this institution reviewing the 
results of surgical repair of 57 TAAs over a 12-year 
period documented a mortality rate of 18% with 16% 
of patients having paraplegia or paraparcsis. 7 
Although the mortality and morbidity of TAA 
repair remain considerable, there are certain sub- 
groups for which repair is safer. One such subgroup is 
the type IV TAA, or aneurysms that involve the entire 
abdominal aorta (from diaphragm to bifurcation) but 
not the thoracic aorta (Fig. 1). The purpose of this 
retrospective r view is to examine the current mor- 
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bidity and mortality of type IV TAA repair at a single 
institution. 
METHODS 
Fifty-eight consecutive patients undergoing repair 
of unruptured atherosclerotic type IV TAA at the 
Brigham & Women's Hospital from 1977 through 
1994 were studied. Patients with type I, II, and III 
TAAs, juxtarenal aortic aneurysms, uprarenal ortic 
aneurysms, acute or chronic dissection, and Marfan's 
syndrome were excluded. Data were obtained by 
review of the Brigham & Women's Hospital Vascular 
Database, hospital charts, and office records. Chart 
review and patient contact were approved by the 
Brigham and Women's Hospital Human Research 
Committee (Protocol Number 94-6747-01). For the 
purposes of evaluating possible improvements in 
outcome over the study period, results were separately 
analyzed for the years 1977 through 1987 and 1988 
through 1994. 
If clinically stable, patients were routinely evalu- 
ated with aortography, abdominal and chest com- 
puted tomography, and cardiology consultation. Re- 
pair was undertaken by one of four full-time vascular 
surgeons practicing during this time period, each of 
whom received specific instruction in aneurysm repair 
during their training and each of whom is listed as a 
coauthor in this study. They were generally assisted by 
either a vascular surgical fellow or chief surgical 
resident. The operative approach varied somewhat 
over the period of study. In the early time period, a 
combined midline/left thoracotomy incision pre- 
dominated, whereas a left retroperitoneal incision 
with circumferential division of the diaphragm was 
used almost exclusively from 1989 through 1994. 
Patients were routinely monitored with radial and 
pulmonary artery catheterization. The use ofheparin 
(5000 U intravenous bolus) and mannitol (I 2.5 to 25 
gm intravenous bolus) before application of the 
cross-clamp was routine. Cold renal perfusion was not 
used in this series. Cerebrospinal fluid pressure was 
kept in the range of 10 to 15 mm Hg when catheter- 
ization was used for spinal cord protection (see 
Results). This was frequently augmented with intra- 
venous corticosteroids (30 mg/ml Solu-Medrol, Up- 
john, Kalamazoo, Mich.) and thiopental sodium (20 
mg/kg). Postoperative pain was controlled with nar- 
cotics delivered intravenously or, in the later time 
period, by an indwelling thoracic epidural catheter. 
Follow-up was established by review of hospital 
charts and office records and, when necessary, tele- 
phone contact with the patient, family, or referring 
physician. Follow-up was limited to the time of hos- 
Fig. 1. Type IV TAA. 
pital discharge in four survivors and was complete in 
the remaining 48. Mean follow-up was 2.4 + 0.3 years 
(median 2 years) with a range of 1 week to 71/2 years. 
Data are presented as mean + SEM unless other- 
wise noted. Survival was calculated with the life-table 
method with comparisons between groups by the log 
rank test. Preoperative and intraoperative predictors 
of survival were identified with either the Kaplan- 
Meier method (discrete variables) or univariate Cox 
regression (continuous variables). Significant covari- 
ates were entered into a Cox model with stepwise re- 
gression by the forward likelihood ratio method. Sta- 
tistical comparisons between the time periods were 
performed with Fisher's exact est (discrete variables) 
or the Mann-Whimey U test (continuous variables). 
Linear regression was performed by the method of 
least-squares. A p value less than 0.05 was considered 
significant. 
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Table  I. Correlation of  patient survival with preoperative and intraoperative variables in 58 patients 
undergoing type IV TAA repair 
No. (percent) or mean + SEM (range) p* 
Age (yr) 70_+ 1 (48-86) 0.6 
Yr of operation (1977-1994) 0.00211 
Male 40 (69) 0.9 
Smoking 53 (91) 0.2 
Hypertension 50 (86) 0.7 
Coronary artery disease 30 (52) 0.7 
Previous aortic reconstruction 22 (38) 0.3 
Chronic obstructive pulmonary disease 11 (19) 0.9 
Previous coronary artery bypass grafting 10 (17) 0.4 
Preoperative dysrhythmia 7 (12) 0.1 
Diabetes mellitus 6 (10) 0.9 
Congestive cardiomyopathy 4 (6.9) 0.2 
Crearinine >2 rag% 10 (18) 0.6 
Asymptomatic atpresentation 25 (43) 0.6 
Abdominal pain 12 (21) 0.7 
Back pain 12 (21) 0.3 
Claudication 13 (22) 0.5 
Uncontrolled hypertension 9 ( 16 ) 0.6 
Weight loss 2 (3.4) 0.5 
Gastrointestinal bleeding 1 (1.7) 0.1 
Pulsatile abdominal mass 14 (24) 0.5 
Aneurysm size (cm)l" 6.5 ± 0.2 (3.5-10) 0.7 
Stenosis/occlusion fceliac, SMA, and/or renal arteries 26 (45) 0.3 
Thoracic epidural analgesia 
Cerebrospinal fluid drainage 
Retroperitoneal pproach 
Visceral ischemia time (min):~ 
Renal ischemia time (min)$ 
Total aortic ischemia time (min)~: 
Blood pressure <90 mmHg during procedure:~ 
Blood pressure <90 mmHg during aortic clamping:~ 
Endarterectomy of celiac, SMA, and/or renal arteries 
Estimated blood loss (L)§ 
Intra-operative blood transfusion (units)§ 
Intra-operative crystalloid infusion (L)§ 
Splenectomy 
35 (60) 0.2 
21 (36) 0.2 
44 (76) 0.021[ 
51 + 3 (19-135) 0.04[1 
57_+4 (19-162) 0.6 
93 + 6 (27-245) 0.8 
27 (48) 0.6 
8 (14) 0.3 
18 (31) 0.2 
5.4 + 1.0 (1.2-60) 0.4 
11 + 1 (2-47) 0.061[ 
8.3 ± 0.5 (2.5-19) 0.2 
9 (16) 0.3 
*Univariate survival analysis by Kaplan-Meier with log-rank test (discrete variables) or Cox regression (continuous variables). 
1-Largest transverse diameter as measured by angiography, computed tomography, magnetic resonance imaging, and/or ultrasonography. 
:~Anesthetic record unavailable in three patients. 
§Excluding intraoperative d ath. 
IL~ < O.lO. 
SMA, Superior mesenteric artery. 
RESULTS 
The number  of  type IV TAA repairs by year is 
given in Fig. 2. A clear increase in case volume 
between the two time periods is evident (13 cases 
between 1977 and 1987 and 45 cases between 1988 
and 1994). Preoperative and intraoperative variables 
are shown in Table I. With univariate analysis 
(p < 0.10) four variables were positively associated 
with survival: later year of  operation (p = 0.002), 
lesser volume of  intraoperative blood transfusion 
(p=0.03) ,  decreased supraceliac ischemia time 
(p= 0.04), and the use of  the retroperitoneal ap- 
proach (p = 0.09). Cox regression analysis revealed 
that the year of  operation was the only independent 
predictor of  survival (p = 0.003). 
Details o f  the patients' postoperativc ourse are 
shown in Table II. Major complications were frequent 
including stroke with permanent  deficit (3.5 %), para- 
plegia ( 1.8 %), permanent paraparesis ( 1.8 %), myocar- 
dial infarction (7%), pneumonia (8.8%), intestinal 
ischemia (5.3%), postoperative hemorrhage requiring 
reexploration (7%), hepatic failure (3.5%), pancreati- 
tis (1.8%), peripheral ischemia (5.3%), in-hospital 
dialysis (8.8%), and permanent  dialysis (1.9%). With 
univariate analysis the following variables were found 
to be significantly decreased uring the 1988 through 
1994 period: days spent in the intensive care unit, days 
spent undergoing mechanical ventilation, total in- 
hospital days, frequency of  postoperative dysrhyth- 
mia, frequency of  postoperative hemorrhage rcquir- 
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Table II. Postoperative course of 58 patients undergoing repair of type IV TAA 
Al l  patients 
(n = 58) 1977-1987 1988-1994 
No. (percent) or (n = 13) (n = 45) 
mean + SEM No. (percent) or No. (percent) 
(range) mean + SEM or mean + SEM p* 
Length of stay (days)]" 
In ICU 7+ 1 (1-62) 18 + 7 6 + 1 
In hospital 25 + 4 (7-193) 46 + 12 21 + 4 
Neurologic dysfunction 
Encephalopathy (transient) I0 (18) 4 (33) 6 (13) 
Stroke (permanent) 2 (3.5) 1 (8.3) 1 (2.2) 
Stroke (transient) 2 (3.5) 1 (8.3) 1 (2.2) 
Paraplegia 1 (1.8) 0 (0.0) 1 (2.2) 
Paraparesis (permanent) 1 (1.8) 0 (0.0) 1 (2.2) 
Paraparesis (transient) 2 (3.5) 1 (8.3) 1 (2.2) 
Cardiac dysfunction 
Myocardial infarction 4 (7.0) 2 (17) 2 (4.4) 
Congestive cardiomyopathy 2 (3.3) 1 (8.3) 1 (2.2) 
Maximum CPK (rag%) 2830 _+ 1010 (305-57,800) 2870 + 790 2820 + 1270 
Dysrhythmia 13 (23) 6 (50) 7 (16) 
Respiratory dysfunction 
Days intubated]" 4 + 1 (0-60) 13 _+ 7 2 + 1 
Pneumonia 5 (8.8) 3 (25) 2 (4.4) 
Gastrointestinal dysfunction 
Clostridium difficilecolitis 2 (3.5) 0 (0.0) 2 (4.4) 
Gastrointestinal bleeding 6 ( l l )  2 (17) 4 (8.9) 
Intestinalischemia 3 (5.3) 1 (8.3) 2 (4.4) 
Hepatic failure 2 (3.5) 0 (0.0) 2 (4.4) 
Maximum SGOT (mg%)~ 365 + 118 (9-5050) 516 + 234 318 + 139 
Pancreatitis 1 (1.8) 0 (0.0) 1 (2.2) 
Renal dysfunction 
Creatinine levation >1 rag% 34 (60) 4 (67) 26 (58) 
Creatinine >3 rag% at discharge 16 (28) 4 (33) 12 (27) 
or death 
In-hospital dialysis 5 (8.8) 3 (25) 2 (4.4) 
Permanent dialysis]" 1 (1.9) 0 (0.0) 1 (2.3) 
Infectious/wound/bleed- 
ing/extremity complications 
Wound infection 4 (7.0) 0 (0.0) 4 (8.9) 
Graft infection 0 (0.0) 0 (0.0)§ 0 (0.0) 
Wound dehiscence 1 (1.8) 1 (8.3) 0 (0.0) 
Hemorrhage r quiring reex- 4 (7.0) 4 (33) 0 (0.0) 
ploration 
Peripheral ischemiarequiring 3 (5.3) 2 (17) 1 (2.2) 
surgical intervention 
Intraoperative mortality 1 (1.7) 1 (7.7) 0 (0.0) 
30-daymortality 3 (5.3) 3 (23) 0 (0.0) 
In-hospitalmortality 6 (10) 5 (39) 1 (2.2) 
0.0411 
0.0211 
0.2 
0.4 
0.4 
0.9 
0.9 
0.4 
0.2 
0.4 
0.1 
0.0311 
0.0211 
0.07 
0.9 
0.6 
0.9 
0.9 
0.0411 
0.9 
0.1 
0.9 
0.07 
0.9 
0.6 
0.9 
0.2 
0.00211 
0.1 
0.2 
0.00911 
0.00211 
ICU, Intensive care unit; CPK, creatinine phospholdnase. 
*Mann-Whitney U-test or Fisher's exact est. 
~'Survivors. 
~Not available in four patients. 
§One patient sustained agraft infection and aorto-duodenal fistula 6 months after operation that was successfully treated. 
ILp < o.o5. 
ing reexploration, and maximum serum glutamic 
oxaloacetic:transaminase (SGOT). The 30-day and 
in-hospital mortality for the 5 8 patients was 5.3% and 
10%, respectively. In-hospital mortality was due to 
multisystem organ failure in four patients, intraopera- 
tive hemorrhage and arrest in one patient, and loss of 
airway with emergent cricothyroidotomy and subse- 
quent multisystem organ failure in one patient. Sig- 
nificant decreases occurred in both 30-day and in- 
hospital mortality during the last 6 years (30-day 
mortality 23% vs 0%, p = 0.009; in-hospital mortality 
39% vs 2.2%, p = 0.02). 
The two patients who had permanent complica- 
tions of spinal ischemia re noteworthy. Both under- 
went repair in 1989. The first patient was an 83-year- 
old woman with mesenteric and aortoiliac ischemia 
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Fig. 2. Number of type IV TAA repairs by year. 
who at operation was found to have extensive athero- 
matous debris throughout the aorta. She required 
aortic endarterectomy from its supraceliac portion to 
the bifurcation and bilateral renal and visceral endar- 
terectomies and left aortofemoral bypass. The total 
aortic clamp time was 64 minutes. She awoke with Tlo 
paraplegia, which did not resolve. She was discharged 
from a rehabilitation facility after 3 months and was 
lost to follow-up. The second patient was a 79-year- 
old man who underwent infrarenal aortic aneurysm 
repair and prosthetic mesh abdominal hernia repair 13 
years earlier and was transferred after undergoing 
an emergent thoracoabdominal exploration for gas- 
trointestinal b eeding. He was found to have a type IV 
TAA and continued rectal hemorrhage, for which he 
underwent reexploration that revealed an aortoen- 
teric fistula at the previous proximal suture line that 
had become aneurysmal. Direct repair was under- 
taken with a total aortic cross-clamp time of 79 
minutes. He awoke with flaccid lower extremities but 
recovered some neurologic function beginning on 
postoperative day 5. He was independent on transfers 
when discharged home from a rehabilitation facility 
after 3 months. He died 3 years later of cardiac-related 
causes. Two further patients had transient paraparesis, 
which was completely resolved at follow-up. Perma- 
nent or transient neurologic deficits were less frequent 
in patients treated with cerebrospinal fluid drainage 
(CSFD), but the difference was not statistically sig- 
nificant (with CSFD 0 of 21, without CSFD 4 of 37; 
p = NS). 
A weak but positive correlation was seen between 
the duration of renal ischemia nd the subsequent rise 
in postoperative creatinine (r2= 0.18). However, 
some patients with relatively short duration of renal 
ischemia had large increases in creatinine, whereas 
others had no increase despite a long period of 
ischemia. Similarly, a weak positive correlation was 
seen between the duration of visceral ischemia nd the 
subsequent maximum SGOT (r 2 = 0.077). No pa- 
tient with visceral ischemia time less than 50 minutes 
sustained a maximum postoperative SGOT of greater 
than 500 mg%. 
Five-year survival for the entire group of 58 
patients was 50%. Late deaths were due to cancer in 
three patients, cardiac-related in two patients, trau- 
matic in one patient, and unknown in five patients. A
comparison between the groups who underwent 
operation between 1977 and 1987 and 1988 and 
1994 revealed a significantly better survival in the 
more modern group (p = 0.0003; Fig. 3). 
D ISCUSSION 
The repair of TAAs continues to carry significant 
morbidity and mortality. In the world's largest experi- 
ence, that ofSvensson et al.,~0 encompassing 31 years 
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Table III. Results of type IV TAA repair (literature review) 
Investigator Study (yr) n 30-Day death Neurologic deficit Renal failure* 
Svensson et al.10,16,17 1960-1991 346 20 15 76 
Cox et al. 9 1966-1991 42 13 4 NR 
This series and 7 1977-1994 58 3 2 16 
Cambria et al. s 1978-1988 15 NR 0 NR 
Hollier et al. 8,si 1980-1991 53 NR 0 NR 
Archer et al. 4,is 1984-1989 15 0 NR NR 
Schmidt et al) 1985-1989 3 0 0 NR 
Fox and Berkowitz 6 1986-1991 27 4 NR NR 
Brecl~voldt et al.s2 1984-1990 8 1 0 1 
Total (weighted averages) 567 41 (8.2%) 21 (4.0%) 93 (2s%) 
NR, Not reported. 
*Postoperative creatinine >3 mg%. 
and 1509 patients, the reported rates of 30-day mor- 
tality, paraplegia/paraparesis, and renal failure requir- 
ing dialysis were 8%, 16%, and 9%. These results are for 
all patients with TAA, however, and it has become 
increasingly clear that repair may be undertaken i  
certain groups of patients with considerably less risk. 
For example, patients who have no symptoms at pre- 
sentation, 5'6'9'i6 have minimal risk factors, 6J°'i6'17 
have limited length of involved aorta, 6,i°j5'i6'18,i9 and 
do not have evidence of  dissection 5,6,9,16,19 can bc ex- 
pected to better tolerate aneurysmectomy. Patients 
with type IV TAA (aneurysms limited to the abdomi- 
nal aorta) should theoretically have a lower risk of 
repair because of avoidance of mid or upper thoracic 
aortic clamping, amaneuver that is associated with a 
higher incidence of neurologic complications. In- 
deed, the published results of repair of type IV TAA 
arc superior to the results of TAA repair in general. 
Incorporating data from all large series, the collected 
mortality is approximately 8%, with neurologic and 
renal complications occurring in 4% and 23% (Table 
III). 
The data rcported hcrein appear to substantiate 
the evolving safety of type IV TAA repair. In the 
decade 1977 through 1987, the intraoperative, 30- 
day, and in-hospital mortality rates were 7.7%, 23%, 
and 39%, respectively. These improved considerably 
during the last 6 years to 0%, 0%, and 2.2%. Although 
this study is limited by its retrospective nature, Cox 
regression analysis revealed that the strongest predic- 
tor of patient survival was the year in which the 
operation was performed. Of course, there is nothing 
inherent about the year in which an operation is 
performed that would affect he results. Rather, the 
aggregate of improvements in management and tech- 
nique explain the appearance oftime as the strongest 
predictor of patient survival. 
Therefore, a subgroup analysis for two separate 
time periods was performed in an attempt to delineate 
the mechanism of the dependence ofresults on the era 
of operation. The most striking differences between 
the two time periods involved the conduct of the op- 
eration. More liberal use of oblique retroperitoneal 
incisions followed the recognition that this approach 
provides uperior exposure of the celiac and distal tho- 
racic aorta. Although this technique was first de- 
scribed in 1808, 20 its widespread application for ab- 
dominal aortic exposure has only been realized over 
the past 15 to 20 years.21Thc preference for full hep- 
arinization developed after several peripheral throm- 
botic complications occurred early in the series. 
Bleeding from graft interstices after hcparinization 
was limited by the conversion to sealed knitted 
Dacron grafts in 1989. Improvements in transfusion 
requirements and coagulopathy were brought about 
by increased surgeon experience, decreased operative 
time, and the routine use of cell-saving devices ince 
the mid-1980s. The increased use of thoracic epidural 
analgesia nd circumferential (as opposed to radial) 
division of the diaphragm reflects the belief that these 
techniques lessen postoperative pulmonary morbid- 
ity. Improvements in ischemia time, blood loss, blood 
and crystalloid transfusion, and intraoperative hy- 
potension all served to lessen the physiologic de- 
rangements ofpatients undergoing major vascular re- 
construction. These technical enhancements, a mani- 
festation of increased institutional experience and 
volume, likely led to the decreased intensive care unit 
stay, incidence of dysrhythmias, elevations in SGOT, 
and requirement for reexploration for bleeding. 
Although a significant improvement in in-hospltal 
death was evident, the incidence of permanent neu- 
rologic deficit actually increased slightly, from 0% (0 
of13) to 4.4% (2 of 45). Many strategies have been 
used to limit the neurologic sequelae of TAA repair 
including identification and reimplantation of in- 
tercostal arteries, ~,13,~6,18 temporary aortic shunting 
via atriofemoral or femorofemoral bypass, n'12'18,i9,22 
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Fig. 3. Survival after type IV TAA repair for patients who underwent operation between 1988 
and 1994 (top) and 1977 and 1987 (bottom). Numerals represent number of patients entering 
each interval. Survival was significantly enhanced for patients who underwent operation between 
1988 and 1994 (p = 0.0003). 
CSFD, 3,6,835,19,23,24 steroid and barbiturate adminis- 
tration, 8hypothermia, 11circulatory arrest, 14'25 nalox- 
one administration, 4'15 preliminary axillofemoral by- 
pass grafting, 26 and, most recently, epidural cooling 
for regional spinal cord hypothermia. 27None has 
been proven to be reliably effective in attenuating 
spinal cord ischemia. CSFD was used in 36% of 
patients in this series. No patient who underwent 
CSFD had a temporary or permanent neurologic 
deficit, although this difference was not statistically 
significant. Our current practice continues to include 
CSFD when supraceliac aortic clamping is antici- 
pated, combined with incorporation of large intercos- 
tal arteries into the proximal anastomosis when tech- 
nically feasible. 
Although elevations in postoperative serum cre- 
atinine were frequent and in-hospital dialysis was 
required in 8.8% of patients, the incidence of renal 
failure requiring permanent dialysis was low (1.9%). 
Furthermore, renal failure did not occur in any patient 
with normal preoperative renal function. Because a 
definite relationship exists between the duration of 
renal ischemia and the degree of postoperative r nal 
dysfunction, continued effort towards limitation of 
renal ischemia while ensuring technical adequacy 
appears justified. 
The overall 5-year survival for this cohort of 
patients undergoing type IV TAA repair was 50%. 
This is clearly inferior to the expected survival of 
matched patients without aneurysmal disease, 28 re- 
flecting the systemic nature of this disease. Further- 
more, examination of the survival curves (Fig..3) 
reveals that the enhanced survival for patients who 
underwent operation in the more recent ime period 
seemed to be due to the improved perioperative 
results, because the curves appear to be largely parallel 
after the first 3 months. These data indicate that 
long-term survival is highly dependent on underlying 
disease and are in accord with the findings of other 
investigators .28 
In summary, the modern surgical results of type IV 
TAA repair approximate those of infrarenal abdomi- 
nal aortic aneurysm. Given the poor outcome of 
expectant therapy for patients with TAA,  29'3° a con- 
tinued aggressive operative approach appears war- 
ranted. 
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